Refining CQAs to Balance Development Flexibility, Product Quality & Patient Safety

• Optimizing specification ranges to eliminate inefficiencies and ensure consistent outcomes
• Evaluating critical quality attributes (CQAs) and defining release specifications to effectively reflect product quality

Speakers:

Emily Lowe

Director - Product Analytical Sciences

AstraZeneca